Candidate gene
| defects in these gene are cause of distal hereditary motor neuropathy  |
|
expression of HSPB1 is an accurate and independent predictive biomarker of aggressive disease with a poor clinical outcome in prostate cancer without ETS-gene rearrangement  |
|
potentail novel serum marker for the diagnosis of chronic obstructive pulmonary disease in the smoking population  |
|
altered expression of this protein in testes showing abnormal spermatogenesis may be related to the pathogenesis of male infertility  |
Marker
|
Therapy target
|
|
System | Type | Disorder | Pubmed |
cancer | | |  |
targeting HSPB1 might offer a useful strategy in cancer treatment | neurology | neurodegenerative | |  |
. PEP1-HSPB1 fusion protein may be a potential therapeutic agent for familial amyotrophic lateral sclerosis patients | cancer | digestive | colon |  |
may be a clinical target in patients with 5-FU-resistant colon cancer | cancer | | |  |
target for interrupting signaling from membrane sex steroid receptors to tumor biology in hormone-responsive cancers |
|